New Weight Loss Drug Boosts Energy and Reduces Appetite Without Side Effects
Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...
People without diabetes can use continuous glucose monitors. But should they?
CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
HME News3d
Cardinal Health ‘really keen’ on diabetes market
Cardinal Health’s planned acquisition of Advanced Diabetes Supply Group for $1.1 billion marries its logistics and ...
Becker's Hospital Review3d
Hims & Hers launches GLP-1 tracker amid shortages
Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.
HealthDay on MSN5d
Diabetes Sick Day Rules: What to Eat, Drink & Do, According to an Expert
Balancing your blood sugar and reducing the risk of health issues can be a challenge for people with diabetes when a cold or ...